RxDoctor Payments Data

Corinna Defrancesco

Family · Fredericktown, MONPI 1558545871

Payments from drug & device makers

$3,452in general payments, 2019–2025

Across 202 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$357
  • AstraZeneca$266
  • Novo Nordisk$229
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$158
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$100
  • plus $838 from 19 others

What the payments were for

  • Food & beverage$3,452100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,452 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide67$77,897
Trelegy ElliptaFluticasone/Umeclidin/Vilanter79$66,808
RexultiBrexpiprazole44$64,584
TrulicityDulaglutide38$48,084
LinzessLinaclotide56$37,258
FarxigaDapagliflozin Propanediol54$35,243
EliquisApixaban40$18,458
JanuviaSitagliptin Phosphate21$17,871
OzempicSemaglutide16$16,843
XareltoRivaroxaban40$14,700
RybelsusSemaglutide13$12,372
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$10,615
Breo ElliptaFluticasone/Vilanterol23$10,437
Stiolto RespimatTiotropium Br/Olodaterol Hcl21$10,325
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,233

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$93$125,981105 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$357$87,860124 claims
AstraZenecaFarxiga, Breztri Aerosphere$266$45,47670 claims
AbbVieLinzess$1,504$37,25856 claims
Novo NordiskOzempic, Rybelsus$229$29,21529 claims
PfizerEliquis$82$18,45840 claims
Boehringer IngelheimStiolto Respimat, Jardiance$87$18,12732 claims
MerckJanuvia$29$17,87121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.

Other family in Fredericktown

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →